✦ LIBER ✦

Why anti-Bcl-2 clinical trials fail: a solution

✍ Scribed by Harazono, Y.; Nakajima, K.; Raz, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.e.030 Why do clinical trials fail? L

✍ G. Sachs; S. Edman; D. DeBonis; D. Vanderburg 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

First demonstration of anti-lymphoma act

✍ Webb, A.; Cunningham, D.; Cotter, F.; Ross, P.; Walters, J.; Judson, I.; Raynaud 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Bcl-2 leads to expression of anti-DNA B

✍ Philip Kuo; Margaret S. Bynoe; Chuansheng Wang; Betty Diamond 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Why Have So Many Drugs with Stellar Resu

✍ STEPHEN H. CURRY 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Pitfalls in the design and analysis of p

✍ Johanna H Van Der Lee; Michael WT Tanck; Judit Wesseling; Martin Offringa 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

A phase I clinical trial of navitoclax,

✍ Cleary, James M.; Lima, Caio Max S. Rocha; Hurwitz, Herbert I.; Montero, Alberto 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 408 KB